Insmed Inc
INSM137.030USD
+1.440+1.06%
Handelsschluss 09/26, 16:00（ET）Kurse um 15 Minuten verzögert
28.93BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Unternehmen
Unternehmensinformationen
BörsenkürzelINSM
Name des UnternehmensInsmed Inc
IPO-datumFeb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
Anzahl der mitarbeiter1271
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 15
Addresse700 Us Highway 202/206
StadtBRIDGEWATER
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl08807
Telefon19089779900
Websitehttps://insmed.com/
BörsenkürzelINSM
IPO-datumFeb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
Dr. Martina Flammer, M.D.
Dr. Martina Flammer, M.D.
Chief Medical Officer
Chief Medical Officer
4.27K
-66.30%
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Chief Financial Officer
Chief Financial Officer
239.00
-98.89%
Mr. Leo Lee
Mr. Leo Lee
Independent Director
Independent Director
--
--
Mr. Bryan Dunn
Mr. Bryan Dunn
Vice President, Investor Relations
Vice President, Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
US
64.28M
69.24%
Japan
22.08M
23.79%
Europe and rest of worldld
6.46M
6.96%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Sep 5
Aktualisiert: Fri, Sep 5
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
Andere
66.88%
Aktionäre
Aktionäre
Anteil
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
Andere
66.88%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
44.44%
Hedge Fund
26.91%
Investment Advisor/Hedge Fund
22.20%
Research Firm
2.99%
Family Office
1.09%
Bank and Trust
0.92%
Sovereign Wealth Fund
0.92%
Pension Fund
0.85%
Individual Investor
0.67%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
807
207.14M
108.81%
-3.07M
2025Q1
804
211.64M
111.66%
-239.74K
2024Q4
767
205.04M
113.32%
-2.57M
2024Q3
712
200.94M
112.58%
+1.71M
2024Q2
657
186.57M
112.00%
+21.58M
2024Q1
564
156.59M
105.42%
-6.86M
2023Q4
544
155.47M
105.16%
-6.81M
2023Q3
515
153.95M
107.69%
-8.46M
2023Q2
506
152.37M
106.87%
-10.75M
2023Q1
511
151.28M
110.90%
-8.90M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Darwin Global Management Ltd
15.40M
8.12%
+2.44M
+18.81%
Mar 31, 2025
The Vanguard Group, Inc.
18.23M
9.61%
+47.77K
+0.26%
Mar 31, 2025
JP Morgan Asset Management
5.41M
2.85%
+2.51M
+86.84%
Mar 31, 2025
T. Rowe Price Associates, Inc.
12.76M
6.73%
+212.23K
+1.69%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.00M
6.85%
-170.21K
-1.29%
Mar 31, 2025
Baker Bros. Advisors LP
5.38M
2.84%
+373.76K
+7.47%
Mar 31, 2025
Capital International Investors
7.20M
3.79%
+81.49K
+1.14%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.34M
1.76%
-1.33M
-28.48%
Mar 31, 2025
State Street Global Advisors (US)
5.75M
3.03%
-358.86K
-5.88%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
Invesco Dorsey Wright Healthcare Momentum ETF
5.42%
BNY Mellon Innovators ETF
3.76%
VanEck Biotech ETF
3.65%
Franklin Genomic Advancements ETF
3.46%
SPDR S&P Biotech ETF
2.5%
ProShares Ultra Nasdaq Biotechnology
2.04%
Invesco Nasdaq Biotechnology ETF
2.04%
Virtus LifeSci Biotech Products ETF
2%
iShares Biotechnology ETF
1.86%
Direxion Daily S&P Biotech Bull 3X Shares
1.43%
Mehr Anzeigen
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil5.42%
BNY Mellon Innovators ETF
Anteil3.76%
VanEck Biotech ETF
Anteil3.65%
Franklin Genomic Advancements ETF
Anteil3.46%
SPDR S&P Biotech ETF
Anteil2.5%
ProShares Ultra Nasdaq Biotechnology
Anteil2.04%
Invesco Nasdaq Biotechnology ETF
Anteil2.04%
Virtus LifeSci Biotech Products ETF
Anteil2%
iShares Biotechnology ETF
Anteil1.86%
Direxion Daily S&P Biotech Bull 3X Shares
Anteil1.43%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
